138 related articles for article (PubMed ID: 22861386)
21. Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy loss.
Gharesi-Fard B; Jafarzadeh L; Zolghadri J; Haghbin H
Iran J Immunol; 2012 Dec; 9(4):234-40. PubMed ID: 23268289
[TBL] [Abstract][Full Text] [Related]
22. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma.
Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA
J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439
[TBL] [Abstract][Full Text] [Related]
23. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
[TBL] [Abstract][Full Text] [Related]
24. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
Matinlauri I; Höckerstedt K; Isoniemi H
Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
[TBL] [Abstract][Full Text] [Related]
25. CD30 serum levels and response to hymenoptera venom immunotherapy.
Foschi FG; Emiliani F; Savini S; Quercia O; Stefanini GF
J Investig Allergol Clin Immunol; 2008; 18(4):279-83. PubMed ID: 18714536
[TBL] [Abstract][Full Text] [Related]
26. CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy.
Hoshimoto K; Hayashi M; Ohkura T
Gynecol Obstet Invest; 2001; 52(1):9-12. PubMed ID: 11549856
[TBL] [Abstract][Full Text] [Related]
27. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
28. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
Contasta I; Berghella AM; Pellegrini P; Adorno D
Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
Kim KH; Oh EJ; Jung ES; Park YJ; Choi JY; Kim DG; Lee KY; Kang CS
Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis C.
Di Cesare E; Spadaro A; Ajello A; Ferraù O; Alessi N; Luigiano C; Melluso R; Freni MA
Clin Chem Lab Med; 2005; 43(8):823-6. PubMed ID: 16201891
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Stone SF; French MA
Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.
Ulusoy H; Kamanli A; Ilhan N; Kuru O; Arslan S; Alkan G; Ozgocmen S
Rheumatol Int; 2012 Dec; 32(12):3857-62. PubMed ID: 22193227
[TBL] [Abstract][Full Text] [Related]
34. ATG induction therapy: long-term effects on Th1 but not on Th2 responses.
Weimer R; Staak A; Süsal C; Streller S; Yildiz S; Pelzl S; Renner F; Dietrich H; Daniel V; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
Transpl Int; 2005 Feb; 18(2):226-36. PubMed ID: 15691277
[TBL] [Abstract][Full Text] [Related]
35. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
[TBL] [Abstract][Full Text] [Related]
38. Distinctive CD26 Expression on CD4 T-Cell Subsets.
Cordero OJ; Rafael-Vidal C; Varela-Calviño R; Calviño-Sampedro C; Malvar-Fernández B; García S; Viñuela JE; Pego-Reigosa JM
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680079
[TBL] [Abstract][Full Text] [Related]
39. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
40. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease.
Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M
Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]